Skip to content

Clinical trial protocols evaluating the effectiveness and safety of endoscopic surgical system for adjunct thoracic surgery

Clinical trial protocols evaluating the effectiveness and safety of endoscopic surgical system for adjunct thoracic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084046
Enrollment
Unknown
Registered
2024-05-09
Start date
2024-05-09
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic surgery

Interventions

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age = 18 age =75 years old, male or female; (2) Endoscopic surgery is required, and there are indications for surgical treatment of segmentectomyt/lobectomy; (3) Preoperative ASA graded grade I-III; (4) The subject voluntarily participates in the clinical trial, and agrees or signs the informed consent form with the consent of his or her guardian; (5) Willing to cooperate and complete trial follow-up and related examinations

Exclusion criteria

Exclusion criteria: (1) Those who have a history of thoracic surgery or other malignant tumors in the past and are judged by the investigator to be unsuitable for enrollment; (2) Those with serious comorbidities (heart, lung, liver, brain, kidney and other diseases) or weak constitution that cannot tolerate general anesthesia or surgery; (3) Those with severe bleeding tendency or coagulation dysfunction; (4) Those who are in the active period of infectious diseases or have other severe non-communicable infections; (5) Immunodeficiency virus (HIV) antibody positive; Treponemal-positive patients; (6) Those with severe allergies, suspected or determined to have alcohol, drugs or drug addiction; (7) Those with a history of epilepsy or psychiatric illness or cognitive impairment; (8) Women who are pregnant, lactating, or planning to become pregnant during the test; (9) Participation in other interventional clinical trials within 3 months prior to signing informed consent; (10) Other situations that the investigator believes is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Surgical success rate;

Secondary

MeasureTime frame
Blood loss;Operation time;Length of hospital stay;Postoperation pain score;Surgeon's satisfaction socre ;Blood transfusion rate;

Countries

China

Contacts

Public ContactJun Zhao

The First Affiliated Hospital of Soochow University

Zhaojia0327@126.com+86 185 5039 9999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026